Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10942499.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 41-year-old woman with a history of endometriosis had breast carcinoma diagnosed and treated with tamoxifen. A pelvic mass was subsequently diagnosed and observed on serial ultrasonographic examinations to increase in size. At surgery extensive endometriosis was found. Exacerbation of endometriosis by tamoxifen may become more common as tamoxifen is used more frequently to reduce the risk of breast cancer among premenopausal women.
Medical subject headings
- Adult
- Antineoplastic Agents, Hormonal
- Antineoplastic Agents, Hormonal/adverse effects
- Antineoplastic Agents, Hormonal/therapeutic use
- Breast Neoplasms
- Breast Neoplasms/drug therapy
- Carcinoma, Ductal, Breast
- Carcinoma, Ductal, Breast/drug therapy
- Endometriosis
- Endometriosis/pathology
- Endometriosis/surgery
- Female
- Humans
- Premenopause
- Tamoxifen
- Tamoxifen/adverse effects
- Tamoxifen/therapeutic use